×

We've got news for you.

Register on BusinessLIVE at no cost to receive newsletters, read exclusive articles & more.
Register now

Brian van Rooyen, CEO of Labat Africa, which has positioned itself to be a major player in the potentially lucrative local market for cannabis products, says its plans will not be affected by a recent US Food and Drug Administration warning that some of these products have serious health risks.

“The FDA has flagged THC, the stuff that makes you high, for recreational purposes, but people will continue to use it for medical purposes. And our focus has been primarily on the medical pharmaceutical side,” Van Rooyen says...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.



Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now